Hydrocephalus Treatment on Persistent Disorder of Consciousness

Status Recruiting

Clinical Trial Summary

After acute brain injury or haemorrhagic stroke, hydrocephalus might participate to consciousness disorder. We plan to explore whether ventriculoperitoneal shunt insertion improves consciousness in patients with vegetative or minimally conscious state and hydrocephalus. Patients with acute brain injury, persistent consciousness disorder and hydrocephalus will be shunted with a detailed follow-up at 3 months combining: clinical evaluation, FluoroDésoxyGlucose positron emission tomography imaging, high density electroencephalogram, electrocardiogram Holter and sympathetic activity by microneurography.

Clinical Trial Description

Persistent disorder of consciousness following acute brain injury is a major public health problem. Advances in intensive care allow a growing number of patients to survive after acute brain injury. However, one third of patients in coma following acute brain injury will not recover a consciousness. To date, no specific treatment has shown its effectiveness in the cognitive recovery of those patients. Few clinical cases suggest that hydrocephalus, which is the impairment of cerebrospinal fluid circulation in the brain, may participate to prolonged disorder of consciousness. Hence treating hydrocephalus with a shunt might improve disorders of consciousness. It is possible to gauge intracranial fluid circulation, that is hydrodynamics quantification, and measure resistance to cerebrospinal fluid outflow. Demonstration of an altered hydrodynamics favours the implantation of a shunt to improve cerebrospinal fluid circulation that might modulate brain region involved in the emergence of consciousness. The study hypothesis is that shunting a patient with persistent disorder of consciousness due to acute brain injury and hydrocephalus might improve his state of consciousness. The neural processes underlying will be assessed through comparative analyses of brain metabolic and electrophysiological signatures. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05219331
Study type	Interventional
Source	University Hospital, Toulouse
Contact	Eric SCHMIDT, MD, PhD
Phone	0561775606
Email	schmidt.e@chu-toulouse.fr
Status	Recruiting
Phase	N/A
Start date	September 16, 2022
Completion date	April 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05954650` - Clinical Validity of the Minimally Conscious State "Plus" and "Minus"
Suspended	`NCT04244058` - Changes in Glutamatergic Neurotransmission of Severe TBI Patients	Early Phase 1
Recruiting	`NCT05285124` - HD-tDCS Combined With Circadian Rhythm Reconstruction and Micro Expression Changes on Consciousness Recovery in Patients With Chronic Disturbance of Consciousness	N/A
Not yet recruiting	`NCT05833568` - Five-day 20-minute 10-Hz tACS in Patients With a Disorder of Consciousness	N/A
Recruiting	`NCT05706831` - Music Intervention and Transcranial Electrical Stimulation for Neurological Diseases	N/A
Completed	`NCT03114397` - Long-term Effect of tDCS in Patients With Disorders of Consciousness	N/A
Active, not recruiting	`NCT03623828` - Treating Severe Brain-injured Patients With Apomorphine	Phase 2
Active, not recruiting	`NCT05734183` - Multisensorial IMmersive Experiences (MIME) in Disorders of Consciousness	N/A
Recruiting	`NCT05714215` - SECONDs' Italian Translation and Transcultural Validation
Completed	`NCT04035655` - Sub-study of the NEURODOC Project : Neurophysiological Evaluation of a Routine Care Open Label tDCS Session	N/A
Active, not recruiting	`NCT05747170` - Olfactory Stimulation in Severe Brain Injury	N/A
Active, not recruiting	`NCT03826407` - Development of a Point of Care System for Automated Coma Prognosis
Recruiting	`NCT03576248` - CONsciousness Transcranial Electric STimulation	N/A
Recruiting	`NCT03611166` - Proteomics for Chronic Disorder of Consciousness
Recruiting	`NCT05382260` - Personal Music for Disorders of Consciousness	N/A
Not yet recruiting	`NCT05820178` - tDCS and rTMS in Patients With Early Disorders of Consciousness	N/A
Recruiting	`NCT05343507` - Ketamine to Treat Patients With Post-comatose Disorders of Consciousness	Phase 2/Phase 3
Completed	`NCT05536921` - Eye Tracking Technology in the Diagnosis of Neurological Patients
Completed	`NCT02647996` - Functional Connectivity Measurement After Severe Traumatic Brain Injury
Recruiting	`NCT04530968` - Metabolic Abnormalities and Intestinal Microecology in Patients With Chronic Disorders of Consciousness

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Hydrocephalus Treatment on Persistent Disorder of Consciousness — HYCO

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms